Top Section/Ad
Top Section/Ad
Most recent
Naturgy and Zurich fall in secondary market after jumbo blocks
Capital raise and investor selldown follow €3bn raise by Engie on Friday evening
UKPN purchase seen as positive by rating agencies, leads to senior and hybrid upgrades
More articles/Ad
More articles/Ad
More articles
-
Swiss duty free operator Dufry has finished its Sfr820m at-market rights issue, which has enabled Advent International and Chinese e-commerce firm to take large strategic stakes in the company.
-
Equity markets swung violently this week as investors reacted to polling and projections in the US election. With over two weeks left before the vote on November 3, equity bankers and investors are predicting a choppy time ahead which might make things trickier for capital markets deals.
-
Urban Logistics Reit, the London-listed real estate investment trust, has finished the final leg of a £92m share sale, tapping into heightened investor demand for exposure to niche areas of the real estate market during the pandemic.
-
China Evergrande Group this week tapped the equity capital markets for HK$4.3bn ($554.9m), making its first primary share sale in five years. But the fundraising did not go as planned, with the embattled property developer nearly halving its initial target after investors called for a smaller deal. Jonathan Breen reports.
-
Synairgen, the UK biopharmaceuticals company, has raised £80m from investors to fund the next stage of clinical trials for a treatment designed to alleviate the respiratory symptoms of Covid-19.
-
Wilhelm Beier, the German billionaire founder of Dermapharm Holding, has trimmed his stake in the pharmaceuticals company.